Today: 9 June 2026
Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed
9 November 2025
3 mins read

Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Published: November 9, 2025

Key points

  • Marriott International ended its licensing agreement with Sonder, citing a “default” by Sonder; Sonder is no longer affiliated with Marriott Bonvoy and its properties have been removed from Marriott’s channels. Reuters+1
  • Marriott now expects 2025 net rooms growth to approach ~4.5%, with no change to other outlook metrics shared last week.
  • Marriott says it will contact guests who booked Sonder stays through Marriott to assist with changes; third‑party OTA bookers should contact their agency.
  • The Marriott–Sonder tie‑up launched in 2024 and scaled in 2025; BTN reports it was envisioned as a 20‑year deal and included $15 million in “key money.” Business Travel News

What changed today

Marriott International said Sunday that its licensing agreement with Sonder Holdings is “no longer in effect due to Sonder’s default.” Effective immediately, Sonder properties are not available for new bookings on Marriott.com, the Marriott Bonvoy app, or Marriott’s call centers, and Sonder is no longer an affiliated brand within Bonvoy. Reuters+1

In a separate financial update, Marriott trimmed its 2025 net rooms growth guidance to ~4.5% following the removal of Sonder inventory, adding that the rest of the outlook it provided on Nov. 4 remains unchanged.

If you have a Sonder reservation booked through Marriott

Marriott says its “immediate priority” is supporting guests currently staying at Sonder properties and those with upcoming reservations made via Marriott channels. The company will reach out to impacted guests to help with modifications, alternative accommodations, or refunds as needed. Travelers who booked a Sonder stay through an online travel agency (e.g., Expedia) should contact that provider directly. PR Newswire

What Bonvoy members need to know

Because Sonder is no longer in the program, you can’t newly earn or redeem Marriott Bonvoy points on Sonder stays. The Points Guy notes that one traveler’s points and night credits from a pre‑termination stay posted normally, but that’s anecdotal; members with in‑progress or imminent reservations should follow Marriott’s guidance and confirm how their specific booking will be handled.

How we got here: a short partnership with big ambitions

The Marriott–Sonder arrangement was announced in 2024 and ramped through 2025 to make apartment‑style Sonder units bookable in Marriott channels. BTN reports the license was expected to run for 20 years (with five‑year termination options), came with undisclosed royalties, and included $15 million in “key money.” BTN also reports the full Sonder inventory appeared in Marriott channels by June 2025. Business Travel News

Reuters previously reported the pact bolstered Sonder’s liquidity by $146 million and envisioned more than 9,000 units joining Marriott’s system, underscoring how material the distribution could have been for both sides.

What “default” might mean (and what we don’t know)

Neither company has publicly detailed which clause was breached. However, Sonder’s Aug. 5, 2025 SEC filing describes events of default under a loan agreement with Marriott, including missed payments, cross‑defaults and a requirement to raise at least $32.5 million in new capital by Nov. 15, 2025. Today’s announcements do not specify whether any of those provisions triggered the termination.

Industry and investor context

Reuters notes Sonder has faced severe financial pressure since going public, with its market value collapsing from a multi‑billion‑dollar SPAC‑era figure to the single‑digit millions. The end of the Marriott tie‑up removes a prominent distribution channel as Sonder negotiates with creditors and landlords to stabilize its business. Marriott, for its part, signaled limited impact beyond the slight rooms‑growth revision.

What travelers should do next

  • Booked via Marriott? Monitor your email/phone for outreach from Marriott and be ready to accept rebooking or refund options. You can also proactively contact Marriott customer service if you need immediate assistance.
  • Booked via an OTA? Contact the OTA (e.g., Expedia, Hotels.com) directly to adjust or rebook.
  • Booked directly with Sonder? Review your confirmation and cancellation terms and reach out to Sonder support; policies may differ from Marriott’s. (General consumer guidance.)
  • Using points? New redemptions at Sonder are no longer possible; for existing points bookings routed through Marriott, confirm your options with Marriott support.

The bottom line

Marriott has abruptly unwound its high‑profile Sonder partnership, citing a Sonder default and pulling Sonder inventory from Bonvoy. Guests with Marriott‑channel reservations will receive direct support from Marriott, while the chain expects only a modest rooms‑growth impact this year. The specific cause of the default remains undisclosed; watch for subsequent filings or statements from Sonder for clarity.


Sources: Reuters; Marriott press statements; The Points Guy; Business Travel News; Upgraded Points.

Stock Market Today

  • Cotton Futures Hold Steady Amid Mixed Trading and Market Moves
    June 9, 2026, 9:23 AM EDT. Cotton futures showed mixed performance on Monday with 5 to 15 point gains in most contracts, except July which fell 25 points by midday. The US dollar index declined to 99.94, while crude oil prices rose by 79 cents. Weekly Commodity Futures Trading Commission (CFTC) data revealed speculative funds reduced their net long positions in cotton by 1,798 contracts to 52,402 as of June 2. The Seam reported sales of 1,311 bales at 74.00 cents per pound, while the Cotlook A Index dropped 135 points to 86.15 cents on Friday. ICE certified cotton stocks increased by 11,219 bales to 261,648 on June 5. Key futures: July cotton at 73.5 cents (down 25), December 77.59 (up 11), March 78.85 (up 5). This reflects cautious market sentiment amid variable data.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown
Previous Story

Alphabet (GOOGL) Stock Today, Nov 7, 2025: Shares Slip ~2.6% as YouTube TV–Disney Blackout Persists; DOJ Clears $32B Wiz Deal

Anduril’s Fury (YFQ‑44A) Completes First Flight in 556 Days, Accelerating the Air Force’s CCA Program — What’s New Today (Nov. 10, 2025)
Next Story

Anduril’s Fury (YFQ‑44A) Completes First Flight in 556 Days, Accelerating the Air Force’s CCA Program — What’s New Today (Nov. 10, 2025)

Go toTop